In the MESA cohort, Pi10 was associated with accelerated lung function decline and increased risk of incident COPD and chronic lower respiratory disease (CLRD) hospitalizations and mortality, independent of initial lung function among participants without clinical lung disease at baseline [48]. Here, SERPINB10 is linked to lower respiratory tract disorder.